Kooby David A, Suriawinata Arief, Klimstra David S, Brennan Murray F, Karpeh Martin S
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
Ann Surg. 2003 Jun;237(6):828-35; discussion 835-7. doi: 10.1097/01.SLA.0000072260.77776.39.
To evaluate factors predictive of survival following curative resection for node-negative gastric adenocarcinoma.
Presence or absence of lymph node metastases is the most powerful predictor of survival following curative resection for gastric adenocarcinoma. Factors predictive of survival in node-negative gastric cancer have not been clarified.
Histopathology and clinical outcome for all patients undergoing R0 resections for gastric adenocarcinoma at a tertiary center between 1985 and 2001 were reviewed.
Of 1,256 R0 resections performed, 507 (40%) were node-negative, 465 were T1-T3, and 317 of these were adequately staged, as defined by histologic evaluation of at least 15 lymph nodes. Median age was 67 years, and 62% were male. Forty percent had T1 tumors, 34% were T2, and 26% were T3. Median tumor size was 3 cm. Vascular invasion (VI) was present in 17% of tumors and neural invasion (NI) in 31%. Extended (D2) lymphadenectomy was performed in 75% of cases. Five- and 10-year disease-specific survival rates were 79% and 67% respectively. Factors associated with poorer disease-specific survival on univariate analysis were male gender, serosal invasion, presence of VI, presence of NI, and resection other than distal subtotal gastrectomy. On multivariate analysis, NI was not an independent predictor of survival, but correlated directly with advancing T stage and tumor size.
Serosal invasion and presence of VI are strong predictors of poor survival in this disease. NI correlates with T stage and tumor size and may serve as a marker of advanced disease.
评估根治性切除术后淋巴结阴性胃腺癌患者生存的预测因素。
有无淋巴结转移是胃腺癌根治性切除术后生存的最有力预测因素。淋巴结阴性胃癌患者生存的预测因素尚未明确。
回顾了1985年至2001年间在一家三级中心接受胃腺癌R0切除的所有患者的组织病理学和临床结果。
在1256例R0切除病例中,507例(40%)为淋巴结阴性,465例为T1-T3期,其中317例经至少15个淋巴结的组织学评估进行了充分分期。中位年龄为67岁,62%为男性。40%的患者为T1期肿瘤,34%为T2期,26%为T3期。肿瘤中位大小为3 cm。17%的肿瘤存在血管侵犯(VI),31%存在神经侵犯(NI)。75%的病例进行了扩大(D2)淋巴结清扫术。5年和10年疾病特异性生存率分别为79%和67%。单因素分析中与较差疾病特异性生存相关的因素为男性、浆膜侵犯、VI的存在、NI的存在以及远端胃次全切除术以外的切除术。多因素分析中,NI不是生存的独立预测因素,但与T分期进展和肿瘤大小直接相关。
浆膜侵犯和VI的存在是该疾病生存不良的有力预测因素。NI与T分期和肿瘤大小相关,可作为疾病进展的标志物。